Connor, Clark & Lunn Investment Management (CC&L)’s GoodRx Holdings GDRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.32M Buy
1,671,521
+236,896
+17% +$1.18M 0.03% 442
2025
Q1
$6.33M Buy
1,434,625
+205,789
+17% +$908K 0.03% 439
2024
Q4
$5.71M Buy
1,228,836
+342,781
+39% +$1.59M 0.03% 451
2024
Q3
$6.15M Sell
886,055
-151,465
-15% -$1.05M 0.03% 390
2024
Q2
$8.09M Sell
1,037,520
-73,217
-7% -$571K 0.03% 316
2024
Q1
$7.89M Buy
1,110,737
+277,381
+33% +$1.97M 0.03% 339
2023
Q4
$5.58M Buy
833,356
+97,154
+13% +$651K 0.03% 391
2023
Q3
$4.14M Sell
736,202
-84,179
-10% -$474K 0.02% 442
2023
Q2
$4.53M Buy
820,381
+120,376
+17% +$664K 0.02% 418
2023
Q1
$4.38M Buy
700,005
+408,405
+140% +$2.55M 0.02% 395
2022
Q4
$1.36M Buy
+291,600
New +$1.36M 0.01% 630